FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

ALKEM

2,422
-1.05 (-0.04%)
Updated 03:29 10/07 IST

ALKEM Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 595,325 for ALKEM
Disclaimer
100% Bullish
0% Bearish

ALKEM Buy or Sell - Brokerage Reports

No. of reports in last year
3
No. of analysts
2
Average Consensus Forecast
2417.67
Consensus Potential
-0.86%
See ALKEM Share Price Targets >>

ALKEM Ratings

Long term ALKEM rating by FrontPage users
5/5 (1 Ratings)
Find answers to all your questions on live ALKEM message board: Is ALKEM buy or sell? Should I buy ALKEM shares? Why are ALKEM shares falling? Should I invest in ALKEM stock?

  1. Home
  2. ALKEM Forum

ALKEM Share Price Discussion

N
Reputation: 3,973 • Yesterday 11:03 AM
Indian pharma market contracts nearly 6% in Q1FY21
Chronic segment that includes drugs for cardiovascular, diabetes, and neuro saw a slump in sales in Q1FY21 due to pre-emptive buying in March
Moneycontrol
Like
Reply
N
Reputation: 3,973 • Jul 9 6:13 AM
Infosys, Bharti Airtel, ICICI Bank among 26 stocks on analysts' radar post Q4 FY20
The market's valuations have turned higher than long-period average and investors should be cautious and selective in picking stocks, say experts .
Moneycontrol
Like
Reply
N
Reputation: 1,096 • Jun 30 7:26 AM

Type
Buy
Instrument
ALKEM
Entry Price
₹2,381.3
Price@Trade
₹2,381.3
Target Price
₹3,500
Stop Price
₹2,200
Valid Till
Jun 30, 2021 3:20 AM
Margin
₹595,325 approx for 250 Qty
Status
Active
Like
Reply

Type
Sell
Instrument
ALKEM
Entry Price
₹2,370.2
Price@Trade
₹2,356.4
Target Price
₹2,320
Stop Price
₹2,399
Valid Till
Jun 29, 2020 3:20 AM
Margin
₹2,370.2 approx for 1 Qty
Status
Expired before entry
Intraday Cash Sell ALKEM @ 2370.20 - 2371 SL 2399 TGT 2320
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jun 29 8:50 AM

Update
Expired before entry
Price @ Update
₹2,351.9
N
Reputation: 3,973 • Jun 26 7:58 AM
Be cautious as fundamentals are weak and valuations seem expensive: Siddhartha Khemka
While the momentum may continue in the near term, one should be cautious going ahead as the fundamentals continue to be weak and valuations seem to be expensive at around 21x FY20 P/E.
Moneycontrol
Like
Reply
A
Reputation: 6,323 • Jun 11 4:38 AM

Type
Sell
Instrument
ALKEM
Entry Price
₹2,348
Price@Trade
₹2,355.1
Target Price
₹2,330
Stop Price
₹2,366
Valid Till
Jun 18, 2020 3:20 AM
Margin
₹117,400 approx for 50 Qty
Status
Exited
Exit Price
₹2,341.7
Net P&L
+₹315 (+0.27%)
4
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 11 5:06 AM

Update
Trade Entered
Entry Price
₹2,348
Ajay Singh @kakosa
Jun 11 5:08 AM

Update
Exited
Exit Price
₹2,341.7
Net P&L
+₹315 (+0.27%)
A
Reputation: 6,323 • Jun 11 4:37 AM

Type
Sell
Instrument
ALKEM
Entry Price
₹2,348
Price@Trade
₹2,356.1
Target Price
₹2,330
Stop Price
₹2,361
Valid Till
Jun 18, 2020 3:20 AM
Margin
₹117,400 approx for 50 Qty
Status
Exited before entry
4
Reply (1)
Latest replies
Ajay Singh @kakosa
Jun 11 4:38 AM

Update
Exited before entry
Price @ Update
₹2,354.95
N
Reputation: 3,973 • Jun 9 7:23 AM
Buy Alkem Laboraties; target of Rs 2850: Motilal Oswal
Motilal Oswal is bullish on Alkem Laboraties has recommended buy rating on the stock with a target price of Rs 2850 in its research report dated June 06, 2020.
Moneycontrol
Like
Reply

Type
Sell
Instrument
ALKEM
Entry Price
₹2,385
Price@Trade
₹2,379.6
Target Price
₹2,360
Stop Price
₹2,405
Valid Till
Jun 8, 2020 3:20 AM
Margin
₹119,250 approx for 50 Qty
Status
Validity Over
Exit Price
₹2,375
Net P&L
+₹500 (+0.42%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jun 8 3:52 AM

Update
Trade Entered
Entry Price
₹2,385
TrackerBot @trackerbot
Jun 8 8:50 AM

Update
Validity Over
Exit Price
₹2,375
Net P&L
+₹500 (+0.42%)
N
Reputation: 3,973 • Jun 8 2:36 AM
Buy Alkem Laboratories, target price Rs 2,882: ICICI Securities
The brokerage is positive on the long-term outlook given the sustainable growth in the domestic market and continued scale-up in US generic business.
The Economic Times
Like
Reply
S
Reputation: 6,772 • Jun 8 1:31 AM

ICICI Securities On Alkem Labs
Upgrade to buy from Add
Price target cut to Rs 2,882 from Rs 3,008
Like
Reply
N
Reputation: 3,973 • Jun 7 1:48 AM
Accumulate Alkem Laboratories; target of Rs 2515: Dolat Capital
Dolat Capital recommended accumulate rating on Alkem Laboratories with a target price of Rs 2515 in its research report dated June 05, 2020.
Moneycontrol
Like
Reply
T
Reputation: 13,241 • Jun 5 10:32 AM
Like
Reply
N
Reputation: 3,973 • Jun 5 10:23 AM
Alkem Laboratories Q4 net profit up 12% at Rs 191.54 crore
Revenue from operations also rose to Rs 2,048.99 crore for the quarter under consideration as against Rs 1,853.03 crore for the same period year ago, it added.
Moneycontrol
Like
Reply
N
Reputation: 3,973 • Jun 5 10:16 AM
Alkem Laboratories Q4 results: Net profit up 12% at Rs 191.54 crore
The company had posted a net profit of Rs 170.50 crore for the corresponding period of previous fiscal.
The Economic Times
Like
Reply
A
Reputation: 6,323 • Jun 3 3:54 AM
Ajay Singh in ALKEM
#ALKEM If price sustains at this level then p...

Price at our trend line
Wait for break out👍🏻👍🏻
2
Reply
A
Reputation: 6,323 • Jun 2 9:25 AM
Ajay Singh in ALKEM
#ALKEM If price sustains at this level then p...
5
Reply
A
Reputation: 6,323 • Jun 2 1:51 AM

ALKEM - chart - 849982
If price sustains at this level then possible level @2400
6
Reply
N
Reputation: 3,973 • May 29 6:38 AM
Building portfolio: Experts bet on 21 scrips to create wealth in coming years
Aashish Somaiyaa of Motilal Oswal Asset Management Company advised that one should avoid panic and remain invested.
Moneycontrol
Like
Reply
N
Reputation: 3,973 • May 28 3:48 AM
Apcotex Ind Standalone March 2020 Net Sales at Rs 115.63 crore, down 23.8% Y-o-Y
Moneycontrol
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • ALKEM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization23,635.03
    Enterprise Value23,904.73
    Price to Earnings33.01
    Price to Book Value4.84
    Return on Capital Employed0.18
    Return on Equity0.15
    Face Value2
    Dividend Yield0.01
  • ALKEM - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    6-Jan-20Ashika Stock BrokingBuy2,423
    6-Jan-20HDFC SecuritiesBuy2,650
    14-Aug-19HDFC SecuritiesBuy2,180
    30-May-19Reliance SecuritiesBuy2,050
    27-Mar-19Motilal OswalBuy2,170
    ALKEM Brokerage Price Target
  • ALKEM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 102407.752446.224052422.35
    Jul 823452439.952332.452427.7
    Jul 72351.952368.0523252335.35
    Jul 62359.9236323252333.6
    Jul 32365236523402350.8
  • ALKEM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹2,354.12
    30 Day Moving Average₹2,360.1
    50 Day Moving Average₹2,419.86
    100 Day Moving Average₹2,471.56
    200 Day Moving Average₹2,273.18
  • ALKEM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue5,3004,668.450.14
    Operating Profit992877.990.13
    Profit Before Tax934894.430.04
    Net Income716883.16-0.19
  • ALKEM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds4,8854,392.650.11
    Total Liabilities2,1111,667.820.27
    Total Assets6,9966,060.470.15
  • ALKEM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity318496.48-0.36
    Cash from Investing Activity-273-361.9-0.25
    Cash from Financing Activity-60-122.06-0.51
    Net Cash Flow-1512.52-2.2
  • ALKEM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.10.15
    Return on Equity0.150.2
    Return on Capital Employed0.180.19
  • ALKEM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.67
    3 Year CAGR Growth in Operating Profit1.41
    3 Year CAGR Growth in EBIDTA0.81
    3 Year CAGR Growth in Net Income0.63
    3 Yr CAGR Growth - Diluted EPS0.63
  • ALKEM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.3
    5 Year CAGR Growth in Operating Profit1.31
    5 Year CAGR Growth in EBIDTA0.8
    5 Year CAGR Growth in Net Income0.53
    3 Yr CAGR Growth - Diluted EPS-0.23
  • ALKEM - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 26 7:58 AM
    Be cautious as fundamentals are weak and valuations seem expensive: Siddhartha Khemka
    Moneycontrol
    NewsBot
    Jun 9 7:23 AM
    Buy Alkem Laboraties; target of Rs 2850: Motilal Oswal
    Moneycontrol
    NewsBot
    Jun 8 2:36 AM
    Buy Alkem Laboratories, target price Rs 2,882: ICICI Securities
    The Economic Times
    NewsBot
    Jun 7 1:48 AM
    Accumulate Alkem Laboratories; target of Rs 2515: Dolat Capital
    Moneycontrol
    NewsBot
    Jun 5 10:23 AM
    Alkem Laboratories Q4 net profit up 12% at Rs 191.54 crore
    Moneycontrol
    NewsBot
    Jun 5 10:16 AM
    Alkem Laboratories Q4 results: Net profit up 12% at Rs 191.54 crore
    The Economic Times
    NewsBot
    May 29 6:38 AM
    Building portfolio: Experts bet on 21 scrips to create wealth in coming years
    Moneycontrol
    NewsBot
    May 28 3:48 AM
    Apcotex Ind Standalone March 2020 Net Sales at Rs 115.63 crore, down 23.8% Y-o-Y
    Moneycontrol
    NewsBot
    May 26 9:48 AM
    Buy Apcotex Industries; target of Rs 120: Emkay Global Financial
    Moneycontrol
    NewsBot
    May 26 7:23 AM
    Sell Apcotex Industries; target of Rs 80: ICICI Direct
    Moneycontrol
  • ALKEM - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020